MASHINIi

NanoVibronix, Inc..

NAOV.US | Manufacture of medical and dental instruments and supplies

NanoVibronix, Inc. is a medical device company that develops noninvasive therapeutic devices. Its products utilize the company's proprietary and patented low intensity surface acoustic wave (LISW) technology. The company's products include PainShield, a disposable patch for local pain relief; UroShi...Show More

Ethical Profile

Mixed.

NanoVibronix, Inc. has faced scrutiny over its business practices. In late 2023, its internal financial reporting controls were deemed ineffective. The company also received Nasdaq delisting notices in 2023 (later regained compliance) and faces an arbitration award of $1,500,250 for an allegedly breached distribution agreement, which is under appeal. Positively, its UroShield device reportedly reduced UTIs by 86% and catheter blockages by 70% in studies. PainShield offers a non-opioid alternative, with 70% of tennis elbow patients seeing significant improvement. However, critics note products are priced at 3-4x production cost, with discount programs reaching only 30-40% of those in need.

Value Scores

Better Health for All40
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

40

NanoVibronix demonstrates a commitment to better health for all through its development and marketing of non-invasive medical devices. UroShield, designed to prevent catheter-associated urinary tract infections (CAUTIs), has shown promising results in reducing UTI incidence by 86% and catheter blockages by 70% in an independent study

1
,
2
. A retrospective case series also showed a 94% average reduction in CAUTIs and catheter blockages, along with a 92% decrease in unplanned hospital visits
3
,
4
,
5
. PainShield offers a non-opioid alternative for pain management, with a clinical study showing 70% of tennis elbow patients experiencing significant improvement
6
,
7
. The company's focus on accessible, at-home treatments and addressing healthcare challenges like biofilm prevention aligns with the value of better health for all. However, the company has a limited number of employees and has operated at a loss, which may impact its ability to scale its impact
8
. The company's products are priced at 3-4x production cost, with discount programs reaching 30-40% of those in need
9
. The company is focused on prevention of infections and pain, rather than just treatment
10
. The company's products have a limited number of adverse events
11
,
12
,
13
. The company's products are used by vulnerable populations
14
. The company's products are alternatives to opioid-based pain management
15
. The company's clinical trials are conducted in accordance with FDA regulations and IRB approvals
16
. The company's products are designed to reduce bacterial colonization on indwelling catheters
17
. The company's products have a significant decrease in UTIs and antibiotic treatment
18
. The company's products have a significant decrease in catheter blockages and changes
19
. The company's products have a mild to moderate pain at baseline, significantly reduced by the end of the trial
20
.

Fair Money & Economic Opportunity

0

NanoVibronix, Inc. is a medical device company that develops and commercializes noninvasive therapeutic devices.

1
The company's products, such as UroShield and PainShield, are approved for reimbursement by national health services like the UK NHS and US CMS, meaning patients do not incur direct costs, APRs, or fees.
2
The company does not offer lending, insurance, or deposit services to consumers, nor does it manage customer financial data, provide debt products, or engage in financial literacy initiatives. Its core business lies outside the scope of financial services, rendering all KPIs related to 'Fair Money & Economic Opportunity' not applicable.

Fair Pay & Worker Respect

0

The company has 16 employees (12 full-time, 4 part-time as of December 2021).

1
No specific data is available for living wage coverage, CEO median pay ratio (as median employee pay is not provided), collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, insecure contract share, or health insurance coverage.
2
The articles explicitly state a lack of data for several of these metrics. For labor violation incidents, no regulatory actions, violations, fines, or compliance issues are mentioned in the provided articles, indicating no public record of such breaches.
3

Fair Trade & Ethical Sourcing

0

No evidence available to assess NanoVibronix, Inc. on Fair Trade & Ethical Sourcing.

Honest & Fair Business

0

As of January 13, 2022, the company's board of directors consisted of eight members, with six considered independent under Nasdaq rules.

1
This represents 75% independent directors.
2

Kind to Animals

0

No evidence available to assess NanoVibronix, Inc. on Kind to Animals.

No War, No Weapons

0

No evidence available to assess NanoVibronix, Inc. on No War, No Weapons.

Planet-Friendly Business

0

No specific, concrete data points are available across any of the Planet-Friendly Business KPIs for NanoVibronix, Inc. The provided articles explicitly state a lack of data for all environmental metrics, including Scope 1, 2, and 3 emissions, renewable energy usage, water consumption, waste diversion rates, and climate-related targets or disclosures.

1
The company's primary focus, as described, is on developing and commercializing noninvasive therapeutic medical devices, and no environmental performance data is reported.
2

Respect for Cultures & Communities

0

The provided articles do not contain specific, concrete data points for any of the KPIs related to Respect for Cultures & Communities. Information regarding formal partnerships, revenue reinvested locally, cultural appropriation incidents, impact assessment protocols, local employment ratios, grievance mechanisms, community complaint resolution times, FPIC participation, community governance inclusion, cultural preservation investment, local procurement, indigenous suppliers, cultural site protection, social license, charitable giving to cultural organizations, community fund allocation, language inclusivity, cultural incident response, or cultural sensitivity training completion is not available.

1

Safe & Smart Tech

0

No evidence available to assess NanoVibronix, Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

No specific, quantifiable data regarding NanoVibronix, Inc.'s waste diversion rate, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability compared to industry standards, repairability, waste audit frequency, zero waste certifications, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education programs is available in the provided articles.

1

Own NanoVibronix, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.